chr3-38756712-ACTT-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 1P and 12B. PM4_SupportingBP6_Very_StrongBS2
The ENST00000449082.3(SCN10A):βc.1249_1251delβ(p.Lys417del) variant causes a inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000982 in 1,614,050 control chromosomes in the GnomAD database, including 2 homozygotes. Variant has been reported in ClinVar as Likely benign (β β ).
Frequency
Genomes: π 0.00072 ( 0 hom., cov: 32)
Exomes π: 0.0010 ( 2 hom. )
Consequence
SCN10A
ENST00000449082.3 inframe_deletion
ENST00000449082.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.46
Genes affected
SCN10A (HGNC:10582): (sodium voltage-gated channel alpha subunit 10) The protein encoded by this gene is a tetrodotoxin-resistant voltage-gated sodium channel alpha subunit. The properties of the channel formed by the encoded transmembrane protein can be altered by interaction with different beta subunits. This protein may be involved in the onset of pain associated with peripheral neuropathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in ENST00000449082.3. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 3-38756712-ACTT-A is Benign according to our data. Variant chr3-38756712-ACTT-A is described in ClinVar as [Likely_benign]. Clinvar id is 420026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-38756712-ACTT-A is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 110 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN10A | NM_006514.4 | c.1249_1251del | p.Lys417del | inframe_deletion | 10/28 | ENST00000449082.3 | NP_006505.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN10A | ENST00000449082.3 | c.1249_1251del | p.Lys417del | inframe_deletion | 10/28 | 1 | NM_006514.4 | ENSP00000390600 | P4 | |
SCN10A | ENST00000643924.1 | c.1249_1251del | p.Lys417del | inframe_deletion | 9/27 | ENSP00000495595 | A1 | |||
SCN10A | ENST00000655275.1 | c.1276_1278del | p.Lys426del | inframe_deletion | 10/28 | ENSP00000499510 |
Frequencies
GnomAD3 genomes AF: 0.000723 AC: 110AN: 152068Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
110
AN:
152068
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000800 AC: 201AN: 251388Hom.: 1 AF XY: 0.000920 AC XY: 125AN XY: 135866
GnomAD3 exomes
AF:
AC:
201
AN:
251388
Hom.:
AF XY:
AC XY:
125
AN XY:
135866
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00101 AC: 1475AN: 1461864Hom.: 2 AF XY: 0.00108 AC XY: 787AN XY: 727238
GnomAD4 exome
AF:
AC:
1475
AN:
1461864
Hom.:
AF XY:
AC XY:
787
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000723 AC: 110AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.000685 AC XY: 51AN XY: 74412
GnomAD4 genome
AF:
AC:
110
AN:
152186
Hom.:
Cov.:
32
AF XY:
AC XY:
51
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 03, 2020 | This variant is associated with the following publications: (PMID: 25053638) - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | SCN10A: PM4:Supporting, BS1, BS2 - |
Brugada syndrome 1 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Brugada syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2023 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at